Selected article for: "abnormal host and acute sars cov respiratory syndrome coronavirus"
Author: Kenny, Grace; Mallon, Patrick W.
Title: COVID19- clinical presentation and therapeutic considerations
  • Cord-id: qts7s4cb
  • Document date: 2020_11_11
    • ID: qts7s4cb
    Snippet: The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as a pandemic infection in 2020 has presented many therapeutic challenges. Not least among these is the importance of abnormal host response to infection that is one of the main drivers of more severe disease. Despite significant research endeavours, very few effective therapies have been identified, in part related to the different pathogenic mechanisms underlying different stages of clinical COVID-19. This mini revie
    Document: The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as a pandemic infection in 2020 has presented many therapeutic challenges. Not least among these is the importance of abnormal host response to infection that is one of the main drivers of more severe disease. Despite significant research endeavours, very few effective therapies have been identified, in part related to the different pathogenic mechanisms underlying different stages of clinical COVID-19. This mini review summarises data related to current and potential future therapies for COVID-19 and highlights the many challenges inherent in developing effective therapeutic options for new pandemic infection.

    Search related documents:
    Co phrase search for related documents
    • abdominal pain and acute stroke: 1, 2, 3, 4
    • abdominal pain and lopinavir ritonavir: 1, 2, 3, 4
    • abdominal pain and low molecular weight heparin: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • abdominal pain nausea vomiting and acute ards respiratory distress syndrome: 1
    • abdominal pain nausea vomiting and lopinavir ritonavir: 1
    • acute ards respiratory distress syndrome and long term effect: 1
    • acute ards respiratory distress syndrome and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute ards respiratory distress syndrome and low molecular weight heparin: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • acute ischaemic stroke and low molecular weight heparin: 1
    • acute stroke and lopinavir ritonavir: 1, 2
    • acute stroke and low molecular weight heparin: 1, 2, 3, 4, 5, 6